Here are relevant reports on : ai-voice-synthesis-market
-
Gene Editing Market by Product (Kits, Reagents, Libraries, Software), Services (gRNA Synthesis & Vector Construction), Technique (Knock-Out, Knock-In), Technology (CRISPR, ZFN, TALEN), Application (Genome Editing, Drug Discovery) - Global Forecast to 2029
The global gene editing market, valued at US$4.44 billion in 2023, stood at US$4.66 billion in 2024 and is projected to advance at a resilient CAGR of 10.2% from 2024 to 2029, culminating in a forecasted valuation of US$7.59 billion by the end of the period. The main factors driving the expansion of this market are the demand for personalized medicine and favorable government funding for gene editing projects.
- Published: November 2024
- Price: $ 4950
- TOC Available:
-
Aminophenol Market by Type (p-aminophenol, m-aminophenol, and o-aminophenol), Application (Dye Intermediate, Synthesis Precursor, Fluorescent Stabilizers), End Use Industry, and Geography – Global Forecast to 2027
The aminophenol market is expected to grow from USD 1.4 billion in 2022 to USD 1.7 billion by 2027, at a CAGR of 4.0% during the forecast period. A few of the key players in the aminophenol market are Wego Chemical Group (US), Parchem (US), CDH Fine Chemicals (India), Glentham Life Sciences Ltd (England), EMCO Dyetuff Pvt Ltd. (India), Loba Chemie (India), Taixing Yangzi Pharm Chemical CO., LTD. (China), Liaoning Shixing Pharmaceutical & Chemical CO., Ltd. (China), and Anhui Bayi Chemical Industry Co. Ltd. (China) among others.
- Published: October 2022
- Price: $ 4950
- TOC Available:
-
Oligonucleotide Synthesis Market by Product ((Drugs (ASO, siRNA), Synthesized Oligos (Product (Primers, Probes)), Type ((Custom, Predesigned), Reagents, Equipment), Application (Therapeutic (Rare Diseases), Research, Diagnostics) - Global Forecast to 2030
The global oligonucleotide synthesis market, valued at US$8.9 billion in 2024, stood at US$10.5 billion in 2025 and is projected to advance at a resilient CAGR of 18.6% from 2025 to 2030, culminating in a forecasted valuation of US$24.7 billion by the end of the period. The oligonucleotide synthesis market is experiencing significant growth, driven by the increasing applications of synthesized oligonucleotides in therapeutics & diagnostics. This growth is supported by technological advancements and rising investments in life sciences research and synthetic biology.
- Published: June 2025
- Price: $ 4950
- TOC Available:
-
Astaxanthin Market by Source (Natural, Synthetic), Form (Dry, Liquid), Method of Production (Microalgae Cultivation, Chemical Synthesis, Fermentation), Application (Dietary Supplements, Food & Beverages, Cosmetics), and Region - Global Forecast to 2026
The global astaxanthin market size was valued to grow from USD 647 million in 2021 to hit USD 965 million by 2026, at a compound annual growth rate (CAGR) of 8.3% during the forecast period. Some of the key players in the market such as Koninklijke DSM N.V. (the Netherlands), BASF SE (Germany), Cyanotech Corporation (US), Otsuka Holdings Co. Ltd. (Japan), Divi’s Laboratories Ltd. (India), Valensa International (US), Fuji Chemical Industries Co. Ltd. (Japan), Beijing Gingko Group (China), Cardax, Inc. (Denmark), Piveg, Inc. (US). Other players in the market are Fenchem Biotek Ltd. (China), Algatech Ltd. (Israel), Supreme Biotechnologies (New Zealand), Igene Biotechnology Inc. (US), Algamo (Czech Republic), Biogenic Co., Ltd. (Japan), Astamaz NZ Ltd. (New Zealand), Algalif (Iceland), Algae to Omega (US), and Algae Health Sciences, Inc. (US).
- Published: August 2021
- Price: $ 4950
- TOC Available:
-
Peptide Synthesis Market by Reagents (Resins, Amino Acid, Dyes), Instruments (Peptide Synthesizer, Chromatography, Lyophilizer), Technique (Solid-phase, Solution-phase, Hybrid), Services, Application (Therapeutics), End User - Global Forecast to 2029
The global peptide synthesis market, valued at US$0.78 billion in 2023, stood at US$0.81 billion in 2024 and is projected to advance at a resilient CAGR of 11.7% from 2024 to 2029, culminating in a forecasted valuation of US$1.41 billion by the end of the period. The peptide synthesis market is driven by the growing demand for therapeutic peptides in treating chronic diseases, including cancer, diabetes, and cardiovascular disorders.
- Published: February 2025
- Price: $ 4950
- TOC Available:
-
Cell-free Protein Synthesis Market by Offering (Cell Extract Systems (Prokaryotic, Mammalian, Plant), Kits, Instruments, Services), Workflow, Method (Coupled TX/TL, Transcription, Translation), Application (Protein Purification) - Global Forecast to 2030
The global cell-free protein synthesis market, valued at US$203.9 million in 2024, stood at US$217.2 million in 2025 and is projected to advance at a resilient CAGR of 7.3% from 2024 to 2030, culminating in a forecasted valuation of US$308.9 million by the end of the period. Market growth is driven by increasing demand for biologics, vaccines, and personalized medicine, advancements in CFPS technologies, the need for quick prototyping of complex proteins, and the demand for commercial-scale validation of cell-free protein expression systems.
- Published: October 2025
- Price: $ 4950
- TOC Available:
-
Retrieval-augmented Generation (RAG) Market by Application (Enterprise Search, Domain-Specific Data Synthesis, Content Summarization and Generation), Type (Foundational & Enhanced, Agentic & Adaptive) - Global Forecast to 2030
The retrieval-augmented generation (RAG) market is estimated to be USD 1.94 billion in 2025 and is projected to reach USD 9.86 billion by 2030, registering a CAGR of 38.4% during 2025–2030. The report profiles key players, such as Microsoft (US), Amazon Web Services, Inc. (US), Anthropic (US), Google (US), IBM (US), Cohere (Canada), NVIDIA (US), Pinecone (US), Elastic N.V. (US), Progress Software Corporation (US), Vectra AI, Inc. (US), Ragie.ai (US), Clarifai (US), Chatbees (US), Zilliz (US), Weaviate (Netherlands), Qdrant (Berlin), and MongoDB (US).
- Published: October 2025
- Price: $ 4950
- TOC Available:
-
CRISPR Market by Offering (Product (Kits, Enzymes, Libraries), Service (gRNA Synthesis, Cell Line Development, Screening, Validation)), Application (Drug Discovery, Development, Agriculture) Competitive Landscape, Company Profiles -Global Forecast to 2030
The global CRISPR market, valued at US$2.90 billion in 2024, stood at US$3.21 billion in 2025 and is projected to advance at a resilient CAGR of 11.2% from 2025 to 2030, culminating in a forecasted valuation of US$5.47 billion by the end of the period. The growing demand for CRISPR-based gene therapies, followed by advancements in CRISPR technology, and the rising government and private investments in CRISPR technology support the market growth. The development of new vaccines for the treatment of genetic diseases and the expansion of industrial and agricultural applications are presenting strong growth opportunities for CRISPR in the coming years.
- Published: May 2025
- Price: $ 4950
- TOC Available:
-
Hexamethylenediamine Market by Application (Nylon Synthesis, Curing Agents, Lubricants, Biocides, Coatings Intermediate, Adhesives), End-Use Industry (Automotive, Textile, Paints & Coatings, Petrochemical) and Region - Global Forecast to 2027
The global hexamethylenediamine market is projected to reach USD 11.6 billion by 2027, moving at a CAGR of 5.4% during the forecast period. The hexamethylenediamine market comprises major solution providers, BASF SE (Germany), Merck KGaA (Germany), TORAY INDUSTRIES, INC. (Japan), Evonik (Germany), and DuPont de Nemours, Inc.(US) among others. The study includes an in-depth competitive analysis of these key players in the hexamethylenediamine market, with their company profiles, and key market strategies.
- Published: July 2022
- Price: $ 4950
- TOC Available:
-
Metal Organic Frameworks Market by Type (Zinc-based, Copper-based, Iron-based, Aluminium-based, Chromium-based), Synthesis Method (Solvothermal/Hydrothermal, Microwave-assisted, Mechanochemical), and Region - Global forecast to 2030
The metal organic frameworks market is expected to grow from USD 0.51 billion in 2024 to USD 1.70 billion by 2030, at a CAGR of 22.1% during the forecast period. Prominent companies include Nanorh (US), Framergy, Inc. (US), novoMOF (Switzerland), BASF SE (Germany), Numat Technologies, Inc. (US), MOFapps (Norway), Nuada (UK), ProfMOF (Norway), ACSYNAM (Canada), Promethean Particles Ltd. (UK), ACMOFS (China), GS Alliance Co., Ltd. (Japan), Physical Sciences Inc. (US), Majd Onsor Fartak (Iran), SyncMOF Inc. (Japan), Immaterial Ltd. (UK), Atomis Inc. (Japan), CD Bioparticles (US), Nanowiz Tech (India), Kerone Engineering Solutions Ltd. (India), Nanoshel LLC (US), Jiangsu Xianfeng Nanomaterial Technology Co., Ltd. (China), Decarbontek, Inc. (US), Svante Technologies Inc. (Canada), Nanochemazone (India)and among others.
- Published: October 2024
- Price: $ 4950
- TOC Available:
Records 31 to 40 of 50
